-
AVITA Medical, Inc. (RCEL) Misses Q3 EPS by 20c ; Offers Guidance
-
BTIG Reiterates Sell Rating on Avita Medical Ltd. (RCEL)
-
Cantor Fitzgerald Reiterates Overweight Rating on Avita Medical Ltd. (RCEL)
-
Avita Medical Ltd. (RCEL) PT Lowered to $14 at D. Boral Capital
-
Lake Street Capital Markets Assumes Avita Medical Ltd. (RCEL) at Buy, PT $8
-
BTIG Downgrades Avita Medical Ltd. (RCEL) to Sell
-
AVITA Medical, Inc. (RCEL) Misses Q2 EPS by 13c
-
Cantor Fitzgerald Reiterates Overweight Rating on Avita Medical Ltd. (RCEL)
-
Avita Medical Limited (RCEL) Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx
-
Cantor Fitzgerald Says Buy Avita Medical Ltd. (RCEL) on Weakness Following Q1 Results
-
AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 21c ; Offers Guidance
-
Avita Medical Limited (RCEL) Launches Cohealyx
-
TD Cowen on Medical Supplies & Devices: 'Companies Least Affected by New Reciprocal Tariffs'
-
Cantor Fitzgerald Reiterates Overweight Rating on Avita Medical Ltd. (RCEL)
-
Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer
-
Cantor Fitzgerald Reiterates Overweight Rating on Avita Medical Ltd. (RCEL)
-
AVITA Medical, Inc. (RCEL) Misses Q4 EPS by 10c, provides guidance
-
Avita Medical Ltd. (RCEL) PT Lowered to $14 at Lake Street Capital Markets
-
After-hours movers: Flutter Entertainment, DraftKings, Cal-Maine Foods, and more
-
Avita Medical Limited (RCEL) Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
-
D. Boral Capital Starts Avita Medical Ltd. (RCEL) at Buy
-
Cantor Fitzgerald Reiterates Overweight Rating on Avita Medical Ltd. (RCEL)
-
Avita Medical Limited (RCEL) Announces FDA Approval of RECELL GO mini
-
Avita Medical Limited (RCEL) Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
-
Avita Medical Limited (RCEL) Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
-
Avita Medical Ltd. (RCEL) PT Raised to $12 at Piper Sandler
-
AVITA Medical, Inc. (RCEL) Misses Q3 EPS by 19c, provides guidance
-
TD Cowen Reiterates Buy Rating on Avita Medical Ltd. (RCEL)
-
Avita Medical Ltd. (RCEL) PT Lowered to $15 at TD Cowen
-
AVITA Medical, Inc. (RCEL) Misses Q2 EPS by 12c, provides guidance
-
BTIG Reiterates Neutral Rating on Avita Medical Ltd. (RCEL)

